Swaminathan Keerthivasagam

7PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersAutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Paediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 17, 2026
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.

Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss

|Jun 24, 2025
Burkitt Lymphoma in a Child With Down Syndrome: A Rare Clinical Association.

Shreyans Patel, Swaminathan Keerthivasagam, Harish Goyal

|May 20, 2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain

|Apr 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain

|Nov 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) Cohort.

Nirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee

|Dec 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort.

Nirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey

Pageof 2

Frequent Collaborators

4 joint publications

Prashant Tembhare

4 joint publications

Nikhil Patkar

3 joint publications

Shyam Srinivasan

3 joint publications

Nirmalya Roy Moulik